Trial intelligence / Profile preview

Mesenchymal Stem Cells for Rectovaginal Fistulas in Crohn's Disease

NCT04519697Phase 2Terminated

Start
Oct 2020
Primary completion
Nov 2023
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of mesenchymal stem cells in rectovaginal fistula (RVF). Started Oct 2020; status: terminated.

02

Drugs

mesenchymal stem cells
03

Conditions

rectovaginal fistula (RVF)

Beyond the preview

Go deeper on NCT04519697.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04519697.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call